Regenxbio

RGNX

NASDAQHealth Care

Income Statement

Total Revenue$83.33M

Gross Profit$49.76M

Operating Income$-233.35M

EBITDA$-198.23M

EBIT$-214.44M

Pre-tax Income$-290.01M

Net Income$-227.1M

Cash Equivalent$73.25M

Total Debt$154.2M

Book Value$325M

Book Value Per Share6.75

Return on Equity (ROE)-87.46%

Return on Assets (ROA)-48.74%

Return on Invested Capital (ROI)-87.46%

Net Profit Margin-272.54%

Current Ratio2.69

Quick Ratio2.61

Long-Term Debt / Equitynull